Jacobsen Capital Management Purchases 37 Shares of Intuitive Surgical, Inc. $ISRG

Jacobsen Capital Management increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 615 shares of the medical equipment provider’s stock after buying an additional 37 shares during the period. Jacobsen Capital Management’s holdings in Intuitive Surgical were worth $334,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. D.A. Davidson & CO. increased its stake in Intuitive Surgical by 2.5% in the 2nd quarter. D.A. Davidson & CO. now owns 13,863 shares of the medical equipment provider’s stock worth $7,533,000 after acquiring an additional 339 shares during the last quarter. Cullen Frost Bankers Inc. grew its holdings in shares of Intuitive Surgical by 1.6% in the second quarter. Cullen Frost Bankers Inc. now owns 78,606 shares of the medical equipment provider’s stock valued at $42,715,000 after purchasing an additional 1,224 shares in the last quarter. Smith Thornton Advisors LLC purchased a new position in shares of Intuitive Surgical in the second quarter valued at $411,000. Whittier Trust Co. of Nevada Inc. increased its position in Intuitive Surgical by 30.5% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 45,129 shares of the medical equipment provider’s stock worth $24,523,000 after purchasing an additional 10,555 shares during the last quarter. Finally, Whittier Trust Co. increased its position in Intuitive Surgical by 41.9% in the second quarter. Whittier Trust Co. now owns 92,965 shares of the medical equipment provider’s stock worth $50,517,000 after purchasing an additional 27,439 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Up 0.9%

NASDAQ:ISRG opened at $462.74 on Wednesday. The company has a market cap of $165.88 billion, a price-to-earnings ratio of 64.54, a price-to-earnings-growth ratio of 4.81 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a fifty day simple moving average of $454.39 and a 200-day simple moving average of $495.58.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.84 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on ISRG shares. UBS Group set a $529.00 price objective on shares of Intuitive Surgical in a research report on Monday, October 13th. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Wells Fargo & Company lifted their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Mizuho reduced their price objective on Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 14th. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $600.00 to $536.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 15th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $585.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.